General Information of Drug Off-Target (DOT) (ID: OTHEDISB)

DOT Name Ragulator complex protein LAMTOR2 (LAMTOR2)
Synonyms
Endosomal adaptor protein p14; Late endosomal/lysosomal Mp1-interacting protein; Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2; Mitogen-activated protein-binding protein-interacting protein; MAPBP-interacting protein; Roadblock domain-containing protein 3
Gene Name LAMTOR2
Related Disease
Adenocarcinoma ( )
Glioma ( )
Hepatocellular carcinoma ( )
Medulloblastoma ( )
Acute myelogenous leukaemia ( )
Acute myocardial infarction ( )
Advanced cancer ( )
Bladder cancer ( )
Breast neoplasm ( )
Clear cell renal carcinoma ( )
Cystic fibrosis ( )
Familial adenomatous polyposis ( )
Hepatitis B virus infection ( )
Hepatitis C virus infection ( )
Immunodeficiency ( )
Liver cirrhosis ( )
Lung cancer ( )
Lung carcinoma ( )
Lymphoma ( )
Neoplasm ( )
Pancreatic cancer ( )
Plasma cell myeloma ( )
Promyelocytic leukaemia ( )
Renal cell carcinoma ( )
Rheumatoid arthritis ( )
Schizophrenia ( )
Severe congenital neutropenia ( )
Sjogren syndrome ( )
Skin cancer ( )
Small lymphocytic lymphoma ( )
Small-cell lung cancer ( )
Squamous cell carcinoma ( )
Systemic lupus erythematosus ( )
Systemic sclerosis ( )
Urinary bladder cancer ( )
Urinary bladder neoplasm ( )
Lung adenocarcinoma ( )
Pediatric lymphoma ( )
Stroke ( )
Primary immunodeficiency syndrome due to p14 deficiency ( )
Carcinoma ( )
Adult lymphoma ( )
Colorectal carcinoma ( )
Intellectual disability ( )
Melanoma ( )
Type-1/2 diabetes ( )
UniProt ID
LTOR2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
5X6U; 5X6V; 5Y39; 5Y3A; 5YK3; 6B9X; 6EHP; 6EHR; 6NZD; 6U62; 6ULG; 6WJ2; 6WJ3; 7T3A; 7T3B; 7T3C; 7UX2; 7UXC; 7UXH; 8DHB
Pfam ID
PF03259
Sequence
MLRPKALTQVLSQANTGGVQSTLLLNNEGSLLAYSGYGDTDARVTAAIASNIWAAYDRNG
NQAFNEDNLKFILMDCMEGRVAITRVANLLLCMYAKETVGFGMLKAKAQALVQYLEEPLT
QVAAS
Function
As part of the Ragulator complex it is involved in amino acid sensing and activation of mTORC1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids. Activated by amino acids through a mechanism involving the lysosomal V-ATPase, the Ragulator plays a dual role for the small GTPases Rag (RagA/RRAGA, RagB/RRAGB, RagC/RRAGC and/or RagD/RRAGD): it (1) acts as a guanine nucleotide exchange factor (GEF), activating the small GTPases Rag and (2) mediates recruitment of Rag GTPases to the lysosome membrane. Activated Ragulator and Rag GTPases function as a scaffold recruiting mTORC1 to lysosomes where it is in turn activated. Adapter protein that enhances the efficiency of the MAP kinase cascade facilitating the activation of MAPK2.
KEGG Pathway
mTOR sig.ling pathway (hsa04150 )
Reactome Pathway
MTOR signalling (R-HSA-165159 )
mTORC1-mediated signalling (R-HSA-166208 )
Energy dependent regulation of mTOR by LKB1-AMPK (R-HSA-380972 )
TP53 Regulates Metabolic Genes (R-HSA-5628897 )
MAP2K and MAPK activation (R-HSA-5674135 )
Neutrophil degranulation (R-HSA-6798695 )
Regulation of PTEN gene transcription (R-HSA-8943724 )
Amino acids regulate mTORC1 (R-HSA-9639288 )
Macroautophagy (R-HSA-1632852 )

Molecular Interaction Atlas (MIA) of This DOT

46 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Adenocarcinoma DIS3IHTY Definitive Posttranslational Modification [1]
Glioma DIS5RPEH Definitive Biomarker [2]
Hepatocellular carcinoma DIS0J828 Definitive Genetic Variation [3]
Medulloblastoma DISZD2ZL Definitive Biomarker [4]
Acute myelogenous leukaemia DISCSPTN Strong Posttranslational Modification [5]
Acute myocardial infarction DISE3HTG Strong Biomarker [6]
Advanced cancer DISAT1Z9 Strong Altered Expression [7]
Bladder cancer DISUHNM0 Strong Posttranslational Modification [8]
Breast neoplasm DISNGJLM Strong Biomarker [9]
Clear cell renal carcinoma DISBXRFJ Strong Genetic Variation [10]
Cystic fibrosis DIS2OK1Q Strong Biomarker [11]
Familial adenomatous polyposis DISW53RE Strong Biomarker [12]
Hepatitis B virus infection DISLQ2XY Strong Biomarker [13]
Hepatitis C virus infection DISQ0M8R Strong Altered Expression [14]
Immunodeficiency DIS093I0 Strong Altered Expression [15]
Liver cirrhosis DIS4G1GX Strong Genetic Variation [16]
Lung cancer DISCM4YA Strong Posttranslational Modification [17]
Lung carcinoma DISTR26C Strong Posttranslational Modification [17]
Lymphoma DISN6V4S Strong Altered Expression [18]
Neoplasm DISZKGEW Strong Biomarker [7]
Pancreatic cancer DISJC981 Strong Genetic Variation [12]
Plasma cell myeloma DIS0DFZ0 Strong Posttranslational Modification [19]
Promyelocytic leukaemia DISYGG13 Strong Posttranslational Modification [5]
Renal cell carcinoma DISQZ2X8 Strong Genetic Variation [10]
Rheumatoid arthritis DISTSB4J Strong Altered Expression [11]
Schizophrenia DISSRV2N Strong Genetic Variation [20]
Severe congenital neutropenia DISES99N Strong Genetic Variation [21]
Sjogren syndrome DISUBX7H Strong Altered Expression [11]
Skin cancer DISTM18U Strong Genetic Variation [22]
Small lymphocytic lymphoma DIS30POX Strong Biomarker [23]
Small-cell lung cancer DISK3LZD Strong Biomarker [24]
Squamous cell carcinoma DISQVIFL Strong Biomarker [25]
Systemic lupus erythematosus DISI1SZ7 Strong Altered Expression [11]
Systemic sclerosis DISF44L6 Strong Altered Expression [11]
Urinary bladder cancer DISDV4T7 Strong Posttranslational Modification [8]
Urinary bladder neoplasm DIS7HACE Strong Posttranslational Modification [8]
Lung adenocarcinoma DISD51WR moderate Altered Expression [26]
Pediatric lymphoma DIS51BK2 moderate Altered Expression [18]
Stroke DISX6UHX moderate Genetic Variation [27]
Primary immunodeficiency syndrome due to p14 deficiency DISJNKN8 Supportive Autosomal recessive [28]
Carcinoma DISH9F1N Disputed Biomarker [29]
Adult lymphoma DISK8IZR Limited Altered Expression [18]
Colorectal carcinoma DIS5PYL0 Limited Posttranslational Modification [30]
Intellectual disability DISMBNXP Limited Biomarker [31]
Melanoma DIS1RRCY Limited Biomarker [32]
Type-1/2 diabetes DISIUHAP Limited Genetic Variation [33]
------------------------------------------------------------------------------------
⏷ Show the Full List of 46 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
12 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Ragulator complex protein LAMTOR2 (LAMTOR2). [34]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Ragulator complex protein LAMTOR2 (LAMTOR2). [36]
Doxorubicin DMVP5YE Approved Doxorubicin increases the expression of Ragulator complex protein LAMTOR2 (LAMTOR2). [37]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Ragulator complex protein LAMTOR2 (LAMTOR2). [38]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Ragulator complex protein LAMTOR2 (LAMTOR2). [39]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Ragulator complex protein LAMTOR2 (LAMTOR2). [40]
Testosterone DM7HUNW Approved Testosterone decreases the expression of Ragulator complex protein LAMTOR2 (LAMTOR2). [41]
Decitabine DMQL8XJ Approved Decitabine affects the expression of Ragulator complex protein LAMTOR2 (LAMTOR2). [42]
Menadione DMSJDTY Approved Menadione affects the expression of Ragulator complex protein LAMTOR2 (LAMTOR2). [43]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Ragulator complex protein LAMTOR2 (LAMTOR2). [44]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Ragulator complex protein LAMTOR2 (LAMTOR2). [45]
chloropicrin DMSGBQA Investigative chloropicrin decreases the expression of Ragulator complex protein LAMTOR2 (LAMTOR2). [46]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the methylation of Ragulator complex protein LAMTOR2 (LAMTOR2). [35]
------------------------------------------------------------------------------------

References

1 EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.Cell Oncol (Dordr). 2011 Jun;34(3):209-14. doi: 10.1007/s13402-011-0028-6. Epub 2011 May 3.
2 Frequent and variable abnormalities in p14 tumor suppressor gene in glioma cell lines.Brain Tumor Pathol. 2008;25(1):9-17. doi: 10.1007/s10014-007-0226-0. Epub 2008 Apr 16.
3 Role of P14 and MGMT gene methylation in hepatocellular carcinomas: a meta-analysis.Asian Pac J Cancer Prev. 2014;15(16):6591-6. doi: 10.7314/apjcp.2014.15.16.6591.
4 Frequent but borderline methylation of p16 (INK4a) and TIMP3 in medulloblastoma and sPNET revealed by quantitative analyses.J Neurooncol. 2007 May;83(1):17-29. doi: 10.1007/s11060-006-9309-8. Epub 2007 Jan 6.
5 Epigenetic dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in acute leukaemias.J Clin Pathol. 2008 Jul;61(7):844-7. doi: 10.1136/jcp.2007.047324.
6 Regenerative Potential of Neonatal Porcine Hearts.Circulation. 2018 Dec 11;138(24):2809-2816. doi: 10.1161/CIRCULATIONAHA.118.034886.
7 An Oncolytic Adenovirus Vector Expressing p14 FAST Protein Induces Widespread Syncytium Formation and Reduces Tumor Growth Rate InVivo.Mol Ther Oncolytics. 2019 May 15;14:107-120. doi: 10.1016/j.omto.2019.05.001. eCollection 2019 Sep 27.
8 Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection.Urol Oncol. 2012 Mar-Apr;30(2):177-81. doi: 10.1016/j.urolonc.2010.01.002. Epub 2010 Aug 25.
9 Association of Mouse Mammary Tumor Virus With Human Breast Cancer: Histology, Immunohistochemistry and Polymerase Chain Reaction Analyses.Front Oncol. 2018 May 7;8:141. doi: 10.3389/fonc.2018.00141. eCollection 2018.
10 Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis.Genes Chromosomes Cancer. 1996 Jan;15(1):64-72. doi: 10.1002/(SICI)1098-2264(199601)15:1<64::AID-GCC9>3.0.CO;2-2.
11 Myeloid calcium binding proteins: expression in the differentiated HL-60 cells and detection in sera of patients with connective tissue diseases.J Biochem. 1990 Oct;108(4):650-3. doi: 10.1093/oxfordjournals.jbchem.a123257.
12 CDKN2A germline mutations in familial pancreatic cancer.Ann Surg. 2002 Dec;236(6):730-7. doi: 10.1097/00000658-200212000-00005.
13 Promoter hypermethylation of p14 (ARF) , RB, and INK4 gene family in hepatocellular carcinoma with hepatitis B virus infection.Tumour Biol. 2014 Mar;35(3):2795-802. doi: 10.1007/s13277-013-1372-0. Epub 2013 Nov 20.
14 Hepatitis C virus Core overcomes all-trans retinoic acid-induced apoptosis in human hepatoma cells by inhibiting p14 expression via DNA methylation.Oncotarget. 2017 Aug 18;8(49):85584-85598. doi: 10.18632/oncotarget.20337. eCollection 2017 Oct 17.
15 A complex immunodeficiency is based on U1 snRNP-mediated poly(A) site suppression.EMBO J. 2012 Oct 17;31(20):4035-44. doi: 10.1038/emboj.2012.252. Epub 2012 Sep 11.
16 Studying the frequency of aberrant DNA methylation of APC, P14, and E-cadherin genes in HCV-related hepatocarcinogenesis.Cancer Biomark. 2018;22(3):503-509. doi: 10.3233/CBM-171156.
17 Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.Int J Cancer. 2003 Oct 10;106(6):913-8. doi: 10.1002/ijc.11322.
18 Primary malignant lymphoma of the brain: frequent abnormalities and inactivation of p14 tumor suppressor gene.Cancer Sci. 2005 Jan;96(1):38-41. doi: 10.1111/j.1349-7006.2005.00003.x.
19 Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma. J Clin Pathol. 2007 Jun;60(6):664-9. doi: 10.1136/jcp.2006.038331.
20 Early Development of Parvalbumin-, Somatostatin-, and Cholecystokinin-Expressing Neurons in Rat Brain following Prenatal Immune Activation and Maternal Iron Deficiency.Dev Neurosci. 2016;38(5):342-353. doi: 10.1159/000454677. Epub 2017 Feb 18.
21 Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia.Br J Haematol. 2009 Feb;144(4):459-67. doi: 10.1111/j.1365-2141.2008.07425.x. Epub 2008 Dec 10.
22 p14ARF hypermethylation is common but INK4a-ARF locus or p53 mutations are rare in Merkel cell carcinoma.J Invest Dermatol. 2008 Jul;128(7):1788-96. doi: 10.1038/sj.jid.5701256. Epub 2008 Jan 24.
23 Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia.J Hum Genet. 2006;51(9):832-838. doi: 10.1007/s10038-006-0029-x. Epub 2006 Aug 3.
24 A 2.5-Mb physical map within 3p21.1 spans the breakpoint associated with Greig cephalopolysyndactyly syndrome.Genomics. 1991 Sep;11(1):93-102. doi: 10.1016/0888-7543(91)90105-n.
25 Frequency of genetic and epigenetic alterations of p14ARF and p16INK4A in head and neck cancer in a Hungarian population.Pathol Oncol Res. 2014 Oct;20(4):923-9. doi: 10.1007/s12253-014-9775-9. Epub 2014 Apr 9.
26 Adenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of Cancer.PLoS One. 2016 Mar 17;11(3):e0151516. doi: 10.1371/journal.pone.0151516. eCollection 2016.
27 Focal Stroke in the Developing Rat Motor Cortex Induces Age- and Experience-Dependent Maladaptive Plasticity of Corticospinal System.Front Neural Circuits. 2017 Jun 29;11:47. doi: 10.3389/fncir.2017.00047. eCollection 2017.
28 Clinical Practice Guidelines for Rare Diseases: The Orphanet Database. PLoS One. 2017 Jan 18;12(1):e0170365. doi: 10.1371/journal.pone.0170365. eCollection 2017.
29 p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.J Ovarian Res. 2016 Oct 22;9(1):69. doi: 10.1186/s13048-016-0275-2.
30 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.BMC Cancer. 2007 May 2;7:72. doi: 10.1186/1471-2407-7-72.
31 Partial tetrasomy with triplication of chromosome (5) (p14-p15.33) in a patient with severe multiple congenital anomalies.Am J Med Genet. 1998 Sep 1;79(2):103-7.
32 Mutual exclusivity analysis of genetic and epigenetic drivers in melanoma identifies a link between p14 ARF and RAR signaling.Mol Cancer Res. 2013 Oct;11(10):1166-78. doi: 10.1158/1541-7786.MCR-13-0006. Epub 2013 Jul 12.
33 Islet biology, the CDKN2A/B locus and type 2 diabetes risk.Diabetologia. 2016 Aug;59(8):1579-93. doi: 10.1007/s00125-016-3967-7. Epub 2016 May 7.
34 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
35 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
36 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
37 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
38 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
39 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
40 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
41 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
42 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
43 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
44 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
45 Genome-wide gene expression profiling of low-dose, long-term exposure of human osteosarcoma cells to bisphenol A and its analogs bisphenols AF and S. Toxicol In Vitro. 2015 Aug;29(5):1060-9.
46 Transcriptomic analysis of human primary bronchial epithelial cells after chloropicrin treatment. Chem Res Toxicol. 2015 Oct 19;28(10):1926-35.